LIVN - LivaNova PLC

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M
• LivaNova names Vladimir Makatsaria as CEO
• LivaNova to wind down Advanced Circulatory Support business unit
• LivaNova reports cybersecurity incident, says IT systems disrupted
• LivaNova PLC Non-GAAP EPS of $0.73 beats by $0.09, revenue of $286.1M beats by $14.24M
• HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead
• AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley
• LivaNova gains regulatory nod for blood monitoring device
• LivaNova PLC beats Q2 top and bottom line estimates; raises FY23 outlook
• LivaNova PLC Non-GAAP EPS of $0.43 beats by $0.04, revenue of $263.4M beats by $19.97M
• LivaNova CEO to step down, co sees preliminary Q1 revenue above consensus
• LivaNova ticks higher amid vague takeover speculation
• LivaNova PLC Non-GAAP EPS of $0.81 beats by $0.08, revenue of $274.9M beats by $12.74M
• LivaNova receives FDA clearance for extracorporeal membrane oxygenation for LifeSPARC
• LivaNova PLC Non-GAAP EPS of $0.58 beats by $0.03, revenue of $252.6M beats by $5.81M
• FDA labels recall of blood bypass pump systems by LivaNova as most serious
• LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
• LivaNova PLC Non-GAAP EPS of $0.48 in-line, revenue of $240.2M beats by $8.63M; reaffirms FY22 guidance
• LivaNova starts targeted commercial launch of Essenz Patient Monitor for heart & lung bypass
• LivaNova PLC Non-GAAP EPS of $0.57 beats by $0.05, revenue of $270.1M beats by $2.9M